by
Published on 08-08-2019 06:30 AM
Centers for Disease Control and Prevention Transcript of August 6, 2019 Press Briefing titled, CDC Vital Signs: Naloxone | site |
(August 7, 2019) - - Today, the Centers for Disease Control and Prevention (CDC) published the following uneditied* version of their August 6, 2019, CDC Vital Signs: Naloxone press briefing transcript:
Tuesday, August 6, 2019
OPERATOR: Welcome, and thank you for standing by. All participants win in listen-only mode until the question-and-answer session. At that time, please press star-one. Please unmute your phone and record your name at the prompt. Today’s conference is being recorded. If you have any objections, you may disconnect at this time. I would now like to turn the call over to your host, Kathy Harben, you may begin.
MODERATOR: Thank you, Malinda, and thank you all for joining us today for the release of a new CDC Vital Signs, which covers trends in pharmacy-based dispensing of naloxone. We’re joined today by CDCs Principal Deputy Director, Dr. Anne Schuchat. She will share
...